Biotech/Biomedical
News Category
CollectionPro Secures $207,575 Federal IDR Victory for Hospital Provider, Ten Times Payer's Offer
CollectionPro won a federal arbitration under the No Surprises Act, securing $207,575 for a hospital provider after the payer offered only $19,108, hi...
Creative Biolabs Advances Neurodegeneration Research with iPSC Models
Creative Biolabs offers advanced iPSC-derived neuronal models to help researchers overcome limitations of traditional animal models and human tissue s...
Microplastic Free Personal Care Polymers Market Projected to Reach USD 1,500.9 Million by 2036 as Beauty Industry Accelerates Sustainable Reformulation
The market for microplastic-free personal care polymers is poised for significant growth, driven by regulatory pressures, consumer demand for sustaina...
Pharmaceutical Omega-3 API Market Set to Double to USD 2.3 Billion by 2036 Driven by Prescription Cardiovascular Therapies
The global pharmaceutical omega-3 API market is projected to grow from USD 1.1 billion in 2026 to USD 2.3 billion by 2036, driven by rising demand for...
Shannon Orthodontics Highlights Braces and Invisalign Options for Kissimmee Patients
Shannon Orthodontics announces its comprehensive orthodontic care in Kissimmee, FL, offering both traditional braces and Invisalign clear aligners wit...
HKSTP Leads Largest-Ever Hong Kong Delegation to BIO 2026, Showcasing Life and Health Tech Strength
Hong Kong Science and Technology Parks Corporation (HKSTP) led a record delegation of 41 organizations to BIO 2026 in San Diego, highlighting Hong Kon...
LataMed AI Enters Fitness and Wellness Sector Through Agreement With Focus Fitness in Venezuela
LataMed AI Corp. announced a strategic agreement with Focus Fitness to deploy its digital health platform for preventative health evaluations and onbo...
Helus Pharma Surpasses 86% Enrollment in Phase 3 APPROACH Trial for Major Depressive Disorder
Helus Pharma announced that its Phase 3 APPROACH trial evaluating HLP003 for major depressive disorder has surpassed 86% enrollment, keeping the compa...
Onco-Innovations Engages Nanosoft to Advance ONC010 Development
Onco-Innovations has partnered with Nanosoft Polymers to support the manufacturing and formulation development of its lead nanoparticle-based PNKP inh...
Helus Pharma Prices $50 Million Public Offering to Advance Mental Health Programs
Helus Pharma announced the pricing of a $50 million public offering to fund development of its novel serotonergic agonist programs for depression and ...
Cardio Diagnostics Expands Access to Precision Cardiovascular Tests Through Atlas Healthcare Physicians
Cardio Diagnostics Holdings announces that Atlas Healthcare Physicians will cover its Epi+Gen CHD and PrecisionCHD tests for eligible members, expandi...
Onco-Innovations Targets Next-Generation DNA Damage Response Cancer Therapies with ONC010(TM)
Onco-Innovations Limited advances a nanoparticle-encapsulated PNKP inhibitor into a $7 billion DDR market, with preclinical success and strategic part...
HeartBeam Reorganizes to Accelerate Global Commercialization of Cardiac Monitoring Technology
HeartBeam restructures leadership to expedite commercialization of its FDA-cleared 3D ECG platform for arrhythmia and heart attack detection, targetin...
Quantum BioPharma's Lucid-MS Targets Myelin Repair in Multiple Sclerosis, Advancing to Phase 2 Trials
Quantum BioPharma's novel drug candidate Lucid-MS, which directly targets myelin sheath repair, is preparing for phase 2 clinical trials, offering a p...
Next-Generation DNA Repair Inhibitors Poised to Capture Billions as Oncology Market Expands
The emerging field of DNA Damage Response inhibitors, beyond established PARP inhibitors, represents a multibillion-dollar opportunity in oncology, wi...
Four Key Factors Driving the Surge in Precious Metal Prices
This article analyzes the recent rally in gold and silver prices, highlighting four forces behind the uptrend and its implications for mining companie...
Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis
Quantum BioPharma is advancing Lucid-MS, a first-in-class drug candidate that directly protects the myelin sheath in multiple sclerosis, toward Phase ...
Cancer Nanomedicine Advances as Onco-Innovations Targets Scalability and Regulatory Readiness
Onco-Innovations' ONC010 combines a PNKP inhibitor with a polymer nanodelivery system to improve tumor targeting and tolerability, with recent manufac...
LakeShore Biopharma Completes Going Private Transaction, Ends Public Trading
LakeShore Biopharma has finalized its merger with Oceanpine Skyline Inc., delisting from public markets and becoming a privately held company, signali...
VERAXA Biotech Advances BiTAC-ADC Platform, Reports New Preclinical Data for Selective Cancer Cell Targeting
VERAXA Biotech AG (NASDAQ: VRXA) has released in vitro proof-of-concept data for its BiTAC-ADC platform, demonstrating selective activity against brea...
New Tooth-Whitening Gel Promises Zero Sensitivity for Users
A new dentist-developed tooth-whitening gel, ioBrite Gentle, offers professional-strength whitening without the sensitivity often caused by peroxide-b...
VERAXA Biotech Reports Positive Preclinical Data for BiTAC-ADC Platform, Seeks Partnerships at BIO 2026
VERAXA Biotech announced new in vitro proof-of-concept data for its BiTAC-ADC platform, showing selective cancer cell destruction, as it prepares to p...
Atticus Goods Plans New Brands and Promotions Through 2026
Atticus Goods expands its online marketplace across consumer electronics, business technology, marine supplies, wellness products, and everyday essent...
Earth Science Tech Inc. Reports Fiscal 2026 Results, Highlighting Revenue and Net Income Growth
Earth Science Tech Inc. (OTC: ETST) announced its fiscal year-end financial results for March 31, 2026, showing an 8% revenue increase to $35.7 millio...
Oncotelic Therapeutics Pivots to AI and Pharmaceutical Automation with New TechForce Robotics Partnership
Oncotelic Therapeutics is expanding beyond its clinical-stage biopharma roots into AI-driven pharmaceutical automation through a strategic partnership...
Veraxa Biotech Expands Heidelberg R&D Facilities to Advance Oncology Pipeline
Veraxa Biotech's expansion of its Heidelberg R&D facilities signals a strategic push to move its BiTAC-based cancer therapies from discovery toward ea...
Scientists Identify Enzyme That Could Block Brain Metastases, Potentially Transforming Cancer Treatment
Researchers from King's College London and McMaster University discovered a molecular pathway critical for cancer migration to the brain, which could ...
Eckert & Ziegler SE Shareholders Approve Higher Dividend for 2025
Eckert & Ziegler SE's Annual General Meeting approved a dividend increase to EUR 0.22 per share for 2025, reflecting strong shareholder confidence.
Eckert & Ziegler SE Shareholders Approve Higher Dividend at Annual General Meeting
Eckert & Ziegler SE's Annual General Meeting approved a dividend increase to EUR 0.22 per share for 2025, reflecting strong shareholder support and co...
Nabaltec AG Shareholders Approve Dividend of EUR 0.29 per Share at Annual General Meeting
Nabaltec AG's Annual General Meeting approved a dividend of EUR 0.29 per share, reflecting shareholder confidence in the company's strategy amid a cha...
Ottobock Appoints Dr. Katarzyna Mazur-Hofsaess to Management Board
Ottobock has appointed Dr. Katarzyna Mazur-Hofsaess to its Management Board, succeeding Stefan Heidenreich, marking a strategic move to leverage her i...
Nabaltec AG Annual General Meeting Approves Dividend of EUR 0.29 per Share
Shareholders of Nabaltec AG approved a dividend of EUR 0.29 per share, reflecting confidence in the company's strategy amid a challenging chemical ind...
Medical Device Contract Manufacturing Market to Surge to $330.35 Billion by 2036 as OEMs Accelerate Outsourcing
The medical device contract manufacturing market is projected to grow from $93.80 billion in 2025 to $330.35 billion by 2036 at a 12.1% CAGR, driven b...
Cold Chain Biologic Temperature Monitoring Labels Market to Reach USD 155.0 Million by 2036 as Biologic Distributors Shift Toward Carton-Level and Vial-Level Release Evidence
The global market for cold chain biologic temperature monitoring labels is projected to grow from USD 60.0 million in 2026 to USD 155.0 million by 203...
Financial Leader Keith D'Agostino Launches New Undergraduate Scholarship for Cancer Survivors
Finance executive Keith D'Agostino introduces a scholarship for undergraduate cancer survivors, focusing on resilience and leadership potential.
Lexaria Begins Dosing in Human Study Evaluating Oral Semaglutide Formulations Against Wegovy
Lexaria Bioscience has initiated a 5-week human pilot study testing two oral DehydraTECH-semaglutide compositions against Novo Nordisk's Wegovy tablet...
HeartBeam Reorganizes to Accelerate Global Commercialization of 3D ECG Platform
HeartBeam Inc. announces a strategic reorganization to streamline decision-making and reduce costs as it advances commercialization of its FDA-cleared...
Quantum BioPharma's Lucid-MS Offers New Hope in Multiple Sclerosis Treatment
Quantum BioPharma Ltd. is featured in a BioMedWire editorial highlighting its novel drug candidate Lucid-MS, which aims to repair myelin damage in mul...
Researchers Warn Against Overuse of Antibiotic Prophylaxis Amid Resistance Concerns
A new publication highlights the risks of antibiotic prophylaxis in driving antimicrobial resistance, urging medical caution and suggesting diagnostic...
Helus Pharma Closes $50 Million Public Offering to Advance Clinical Pipeline
Helus Pharma completed a $50 million public offering, with proceeds allocated to Phase 3 trials for major depressive disorder and other pipeline asset...
American Fusion Finalizes Testing Protocol for 5MW Texatron Fusion Engine, Advances Toward Commercial Validation
American Fusion Inc. has finalized the testing protocol for its 5MW pre-production Texatron Fusion Engine, marking a key step toward commercial fusion...
Onco-Innovations Featured in BioMedWire Editorial on Emerging DNA Repair Inhibitors
Onco-Innovations Limited is highlighted in a BioMedWire editorial discussing the growing market for next-generation DNA Damage Response inhibitors, wi...
Former Medtronic CEO Bill Hawkins Joins Ketryx Board to Tackle AI Compliance in Life Sciences
William A. Hawkins, former Chairman and CEO of Medtronic, has joined Ketryx's Board of Directors and participated in its Series B financing to help so...
Cardio Diagnostics Expands Access to Precision Cardiovascular Tests Through Atlas Healthcare Physicians
Cardio Diagnostics Holdings (CDIO) expands coverage of its Epi+Gen CHD and PrecisionCHD tests to members of Atlas Healthcare Physicians, improving acc...